Quality Assessment of Clinical Practice Guidelines on the Treatment of Psoriasis Using the AGREE II Tool.

Evaluación de la calidad de guías de práctica clínica para el tratamiento de psoriasis mediante la herramienta AGREE II.
Clinical guidelines Clinical practice guidelines Guía de práctica clínica Guías clínicas Psoriasis Tratamiento Treatment

Journal

Actas dermo-sifiliograficas
ISSN: 1578-2190
Titre abrégé: Actas Dermosifiliogr
Pays: Spain
ID NLM: 0373062

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 06 04 2021
revised: 22 09 2021
accepted: 26 09 2021
entrez: 8 5 2022
pubmed: 9 5 2022
medline: 11 5 2022
Statut: ppublish

Résumé

Clinical practice guidelines (CPGs) are designed to help health professionals provide patients with excellent medical care. The last critical appraisal of CPGs on the treatment of psoriasis evaluated publications up to 2009, but several new guidelines have been published since and their methodological quality remains unclear. The aim of this study was to systematically evaluate the quality of CPGs on the treatment of psoriasis published between 2010 and 2020 using the Appraisal Guidelines Research and Evaluation II (AGREE II) tool. We searched for relevant CPGs in MEDLINE, Embase, and LILACS (Latin American and Caribean Health Sciences Literature) as well as in the gray literature. Two reviewers working independently selected the guidelines for analysis and extracted the relevant data. Each guideline was then assessed using the AGREE II instrument by 5 reviewers, also working independently. Nineteen CPGs met the inclusion criteria and most of them had been produced in high-income countries. The mean (SD) domain scores were 84.9% (14.7%) for scope and purpose, 65.5% (19.3%) for stakeholder involvement, 66.7% (15.6%) for rigor of development, 72.8% (16.8%) for clarity of presentation, 46.6% (21.7%) for applicability, and 57.0% (30.4%) for editorial independence. Although about three-quarters of the CPGs assessed were judged to be of high quality and over half were recommended for use in clinical practice, standards of guideline development need to be raised to improve CPG quality, particularly in terms of applicability and editorial independence, which had the lowest scores in our evaluation.

Sections du résumé

BACKGROUND BACKGROUND
Clinical practice guidelines (CPGs) are designed to help health professionals provide patients with excellent medical care. The last critical appraisal of CPGs on the treatment of psoriasis evaluated publications up to 2009, but several new guidelines have been published since and their methodological quality remains unclear.
OBJECTIVE OBJECTIVE
The aim of this study was to systematically evaluate the quality of CPGs on the treatment of psoriasis published between 2010 and 2020 using the Appraisal Guidelines Research and Evaluation II (AGREE II) tool.
MATERIAL AND METHODS METHODS
We searched for relevant CPGs in MEDLINE, Embase, and LILACS (Latin American and Caribean Health Sciences Literature) as well as in the gray literature. Two reviewers working independently selected the guidelines for analysis and extracted the relevant data. Each guideline was then assessed using the AGREE II instrument by 5 reviewers, also working independently.
RESULTS RESULTS
Nineteen CPGs met the inclusion criteria and most of them had been produced in high-income countries. The mean (SD) domain scores were 84.9% (14.7%) for scope and purpose, 65.5% (19.3%) for stakeholder involvement, 66.7% (15.6%) for rigor of development, 72.8% (16.8%) for clarity of presentation, 46.6% (21.7%) for applicability, and 57.0% (30.4%) for editorial independence.
CONCLUSIONS CONCLUSIONS
Although about three-quarters of the CPGs assessed were judged to be of high quality and over half were recommended for use in clinical practice, standards of guideline development need to be raised to improve CPG quality, particularly in terms of applicability and editorial independence, which had the lowest scores in our evaluation.

Identifiants

pubmed: 35526917
pii: S0001-7310(21)00376-8
doi: 10.1016/j.ad.2021.09.004
pii:
doi:

Types de publication

Journal Article

Langues

eng spa

Sous-ensembles de citation

IM

Pagination

222-235

Informations de copyright

Copyright © 2021 AEDV. Publicado por Elsevier España, S.L.U. All rights reserved.

Auteurs

C Montesinos-Guevara (C)

Universidad UTE. Facultad de Ciencias de la Salud Eugenio Espejo, Centro de Investigación en Epidemiología Clínica y Salud Pública (CISPEC), Quito, Ecuador.

A Andrade Miranda (A)

Centro Cochrane Asociado - Instituto Universitario Hospital Italiano, Buenos Aires, Argentina. Electronic address: andreaa_11@hotmail.com.

E Bedoya-Hurtado (E)

Departamento de Dermatología, Instituto de Dermatologia Professor Rubem David Azulay, Hospital Santa Casa de Misericórdia do Rio de Janeiro, Río de Janeiro, Brasil.

C M Escobar Liquitay (CM)

Centro Cochrane Asociado - Instituto Universitario Hospital Italiano, Buenos Aires, Argentina.

J V A Franco (JVA)

Centro Cochrane Asociado - Instituto Universitario Hospital Italiano, Buenos Aires, Argentina.

D Simancas-Racines (D)

Universidad UTE. Facultad de Ciencias de la Salud Eugenio Espejo, Centro de Investigación en Epidemiología Clínica y Salud Pública (CISPEC), Quito, Ecuador.

Y Sami Amer (Y)

Departamento de Pediatría y Unidad de Guías de Práctica Clínica, Departamento de Gestión de Calidad, Universidad King Saud Medical City, Riad, Arabia Saudita, Cátedra de Investigación para la Transferencia del Conocimiento y Atención de la Salud Basada en la Evidencia, Universidad King Saud, Riad, Arabia Saudita, Centro de Alejandría para Guías de Práctica Clínica basadas en la evidencia, Universidad de Alejandría, Alejandría, Egipto.

R W M Vernooij (RWM)

Departamento de Nefrología e Hipertensión, Centro Médico Universitario de Utrecht, Universidad de Utrecht, Utrecht, Holanda, Centro Julius de Ciencias de la Salud y Atención Primaria, Centro Médico Universitario de Utrecht, Universidad de Utrecht, Utrecht, Holanda.

A Viteri-García (A)

Universidad UTE. Facultad de Ciencias de la Salud Eugenio Espejo, Centro de Investigación en Epidemiología Clínica y Salud Pública (CISPEC), Quito, Ecuador.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH